BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37799722)

  • 21. Characteristics of lymphocyte subsets and cytokine profiles of patients with COVID-19.
    Pan P; Du X; Zhou Q; Cui Y; Deng X; Liu C; Hu Z; Chen J; Yu X; Shi W
    Virol J; 2022 Mar; 19(1):57. PubMed ID: 35346253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-world effectiveness of molnupiravir, nirmatrelvir-ritonavir, and sotrovimab on preventing hospital admission among higher-risk patients with COVID-19 in Wales: A retrospective cohort study.
    Evans A; Qi C; Adebayo JO; Underwood J; Coulson J; Bailey R; Lyons R; Edwards A; Cooper A; John G; Akbari A
    J Infect; 2023 Apr; 86(4):352-360. PubMed ID: 36773891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of peripheral blood lymphocyte subsets in critical patients at ICU admission: A preliminary investigation of their role in the prediction of sepsis during ICU stay.
    Frattari A; Polilli E; Primiterra V; Savini V; Ursini T; Di Iorio G; Parruti G
    Int J Immunopathol Pharmacol; 2018; 32():2058738418792310. PubMed ID: 30114952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte Phenotyping and HLA-DR Expression over the Course of COVID-19 Infection in Patients with Different Disease Severity.
    Asmaa-Nafady ; Alaa-Rashad ; Nafady-Hego H; Nasif KA; Ebtessam-Elgezawy ; Elrahman NA; Osman HA
    Clin Lab; 2022 May; 68(5):. PubMed ID: 35536080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study.
    Zhang J; Wang Z; Wang X; Hu Z; Yang C; Lei P
    Front Immunol; 2021; 12():581469. PubMed ID: 33664741
    [No Abstract]   [Full Text] [Related]  

  • 26. T cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe disease and death.
    Belaid B; Lamara Mahammad L; Mihi B; Rahali SY; Djidjeli A; Larab Z; Berkani L; Berkane I; Sayah W; Merah F; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Ayoub S; Hamidi RM; Derrar F; Gharnaout M; Allam I; Djidjik R
    J Leukoc Biol; 2022 Jan; 111(1):269-281. PubMed ID: 33527487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum LD1 isoenzyme and blood lymphocyte subsets as prognostic indicators for severe acute respiratory syndrome.
    Chan MH; Wong VW; Wong CK; Chan PK; Chu CM; Hui DS; Suen MW; Sung JJ; Chung SS; Lam CW
    J Intern Med; 2004 Apr; 255(4):512-8. PubMed ID: 15049886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased T cell populations contribute to the increased severity of COVID-19.
    Liu R; Wang Y; Li J; Han H; Xia Z; Liu F; Wu K; Yang L; Liu X; Zhu C
    Clin Chim Acta; 2020 Sep; 508():110-114. PubMed ID: 32405080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic and predictive significance of circulating biomarkers in patients with advanced upper gastrointestinal cancer undergoing systemic chemotherapy.
    Li N; Gao L; Ge Y; Zhao L; Bai C; Wang Y
    Front Oncol; 2023; 13():1195848. PubMed ID: 37346066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nirmatrelvir or Molnupiravir Use and Severe Outcomes From Omicron Infections.
    Lin DY; Abi Fadel F; Huang S; Milinovich AT; Sacha GL; Bartley P; Duggal A; Wang X
    JAMA Netw Open; 2023 Sep; 6(9):e2335077. PubMed ID: 37733342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphocyte Subset Counts in COVID-19 Patients: A Meta-Analysis.
    Huang W; Berube J; McNamara M; Saksena S; Hartman M; Arshad T; Bornheimer SJ; O'Gorman M
    Cytometry A; 2020 Aug; 97(8):772-776. PubMed ID: 32542842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.
    Xie Y; Choi T; Al-Aly Z
    JAMA Intern Med; 2023 Jun; 183(6):554-564. PubMed ID: 36951829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [T lymphocyte subsets combined with inflammatory indicators for auxiliary diagnosis and prognosis evaluation of sepsis].
    Li FF; Yang L; Wang DQ; He WJ; Wang C; Mu H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Apr; 56(4):494-502. PubMed ID: 35488549
    [No Abstract]   [Full Text] [Related]  

  • 34. The informative value of CD3+CD4+ and CD3+CD8+ T-cell count and cHIS scale as predictors of severe COVID-19 when using interleukin-6 receptor blockers in the in-hospital setting.
    Kruglova TS; Fomina DS
    Ter Arkh; 2022 Dec; 94(11):1294-1302. PubMed ID: 37167168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?
    Sun DW; Zhang D; Tian RH; Li Y; Wang YS; Cao J; Tang Y; Zhang N; Zan T; Gao L; Huang YZ; Cui CL; Wang DX; Zheng Y; Lv GY
    Clin Chim Acta; 2020 Sep; 508():122-129. PubMed ID: 32417210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral blood CD3 and CD4 T-lymphocyte reduction correlates with severity of liver cirrhosis.
    Lombardo L; Capaldi A; Poccardi G; Vineis P
    Int J Clin Lab Res; 1995; 25(3):153-6. PubMed ID: 8562979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
    Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
    BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of Pembrolizumab on T Lymphocyte Subsets in Patients with Advanced 
Non-small Cell Lung Cancer and Its Therapeutic Effect].
    Wang Y; Wang Y; Jiang M; Zhao Y; Zhang X
    Zhongguo Fei Ai Za Zhi; 2021 Mar; 24(3):182-187. PubMed ID: 33819968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poor Survival in COVID-19 Associated with Lymphopenia and Higher Neutrophile-Lymphocyte Ratio.
    Montiel-Cervantes LA; Medina G; Pilar Cruz-Domínguez M; Pérez-Tapia SM; Jiménez-Martínez MC; Arrieta-Oliva HI; Carballo-Uicab G; López-Pelcastre L; Camacho-Sandoval R
    Isr Med Assoc J; 2021 Mar; 23(3):153-159. PubMed ID: 33734627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral blood T-lymphocyte subsets are potential biomarkers of disease severity and clinical outcomes in patients with ulcerative colitis: a retrospective study.
    Geng B; Ding X; Li X; Liu H; Zhao W; Gong H; Tian Z; Guo J
    BMC Gastroenterol; 2023 Apr; 23(1):136. PubMed ID: 37106335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.